These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35060378)

  • 1. Dose Number as a Tool to Guide Lead Optimization for Orally Bioavailable Compounds in Drug Discovery.
    Wuelfing WP; El Marrouni A; Lipert MP; Daublain P; Kesisoglou F; Converso A; Templeton AC
    J Med Chem; 2022 Feb; 65(3):1685-1694. PubMed ID: 35060378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational formulation strategy from drug discovery profiling to human proof of concept.
    Ayad MH
    Drug Deliv; 2015; 22(6):877-84. PubMed ID: 24670097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in small molecule drug properties: A developability molecule assessment perspective.
    Agarwal P; Huckle J; Newman J; Reid DL
    Drug Discov Today; 2022 Dec; 27(12):103366. PubMed ID: 36122862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The graphical representation of ADME-related molecule properties for medicinal chemists.
    Ritchie TJ; Ertl P; Lewis R
    Drug Discov Today; 2011 Jan; 16(1-2):65-72. PubMed ID: 21074634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.
    Dahan A; Miller JM
    AAPS J; 2012 Jun; 14(2):244-51. PubMed ID: 22391790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists.
    Bonnet P
    Eur J Med Chem; 2012 Aug; 54():679-89. PubMed ID: 22749644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing Oral Bioavailability in Drug Discovery: An Overview of Design and Testing Strategies and Formulation Options.
    Aungst BJ
    J Pharm Sci; 2017 Apr; 106(4):921-929. PubMed ID: 27986598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of suitable formulations for high dose oral studies in rats using in vitro solubility measurements, the maximum absorbable dose model, and historical data sets.
    Wuelfing WP; Kwong E; Higgins J
    Mol Pharm; 2012 May; 9(5):1163-74. PubMed ID: 22394323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting biopharmaceutical performance of oral drug candidates - Extending the volume to dissolve applied dose concept.
    Muenster U; Mueck W; van der Mey D; Schlemmer KH; Greschat-Schade S; Haerter M; Pelzetter C; Pruemper C; Verlage J; Göller AH; Ohm A
    Eur J Pharm Biopharm; 2016 May; 102():191-201. PubMed ID: 26955751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding the sweet spot: the role of nature and nurture in medicinal chemistry.
    Hann MM; Keserü GM
    Nat Rev Drug Discov; 2012 Apr; 11(5):355-65. PubMed ID: 22543468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of physicochemical and molecular properties in drug design: navigation in the "drug-like" chemical space.
    Vallianatou T; Giaginis C; Tsantili-Kakoulidou A
    Adv Exp Med Biol; 2015; 822():187-94. PubMed ID: 25416989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical profiling (solubility, permeability and charge state).
    Avdeef A
    Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs.
    Bergström CA; Holm R; Jørgensen SA; Andersson SB; Artursson P; Beato S; Borde A; Box K; Brewster M; Dressman J; Feng KI; Halbert G; Kostewicz E; McAllister M; Muenster U; Thinnes J; Taylor R; Mullertz A
    Eur J Pharm Sci; 2014 Jun; 57():173-99. PubMed ID: 24215735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound aggregation in drug discovery: implementing a practical NMR assay for medicinal chemists.
    LaPlante SR; Carson R; Gillard J; Aubry N; Coulombe R; Bordeleau S; Bonneau P; Little M; O'Meara J; Beaulieu PL
    J Med Chem; 2013 Jun; 56(12):5142-50. PubMed ID: 23730910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating drug permeability with dissolution profile to develop IVIVC.
    Takano R; Kataoka M; Yamashita S
    Biopharm Drug Dispos; 2012 Oct; 33(7):354-65. PubMed ID: 22581486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the solubility parameter concept to assist with oral delivery of poorly water-soluble drugs - a PEARRL review.
    Jankovic S; Tsakiridou G; Ditzinger F; Koehl NJ; Price DJ; Ilie AR; Kalantzi L; Kimpe K; Holm R; Nair A; Griffin B; Saal C; Kuentz M
    J Pharm Pharmacol; 2019 Apr; 71(4):441-463. PubMed ID: 29978475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral delivery of poorly soluble compounds by supersaturated systems.
    Lee TW; Boersen NA; Hui HW; Kurtulik P
    Ther Deliv; 2011 Jun; 2(6):685-90. PubMed ID: 22822502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interesting relationship between drug absorption and melting point.
    Chu KA; Yalkowsky SH
    Int J Pharm; 2009 May; 373(1-2):24-40. PubMed ID: 19429285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.